Figure 1.
Post-HCT outcomes for 810 adults with AML undergoing allogeneic HCT while in first or second morphologic remission, stratified by early peri-HCT MRD dynamics. (A) Risk of relapse, (B) RFS, (C) OS, and (D) risk of NRM, shown for the entire study cohort.